Keros Therapeutics, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Keros Therapeutics, Inc. (KROS) had Convertible Preferred Stock, Shares Issued upon Conversion of 10.73 million shares as of 2020-03-31, per its 10-Q filed 2020-05-22.
Discontinued › Notes › Equity
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2021-03-25
- 2020-03-31: Convertible Preferred Stock, Shares Issued upon Conversion 10.73M shares.
- 2019-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 6.56M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2020-03-31 | 10.73M shares 10-Q · filed 2020-05-22 |
| 2019-12-31 | 6.56M shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |